Skip to content

multi-omics study in patients with pelvic lipomatosis

A Cross-Sectional Observational Study on Multi-Omics Characteristics of Patients with Pelvic Lipomatosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104944
Enrollment
Unknown
Registered
2025-06-25
Start date
2025-06-26
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Lipomatosis

Interventions

Observation group:None

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1 Males aged 18 years or older. 2 Meet the diagnostic criteria: (1) Clinical symptoms (lower urinary tract symptoms, hematuria, constipation). (2) Imaging (CT or MRI indicating abnormal pelvic fat accumulation, bladder compression and deformation, elongated position, elevated prostate position, variations in ureter position, and upper urinary tract hydronephrosis). (3) Physical examination (digital rectal examination indicating significant elongation of the posterior urethra and difficulty in palpating the prostate). (4) Cystoscopy (biopsy indicating adenocystitis). Diagnosis of pelvic fat excess syndrome can be made if all four of the above criteria are met. 3 Able to provide blood, urine, and tissue samples required for the study. 4 Willing to cooperate with treatment and research and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. A history of other cancers. 2. Coexisting severe organ diseases. 3. Mental disorders. 4. Death due to reasons other than the disease during the follow-up period.

Design outcomes

Primary

MeasureTime frame
urinary metabolites;urinary hormone levels;

Countries

China

Contacts

Public Contactchenhaige

Renji Hospital, Shanghai Jiao Tong University School of Medicine

kirbyhaige@aliyun.com+86 188 1765 2267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026